Femme et Homme
- | Pays :
- Russian Federation
- France
- | Organes : -
- | Spécialités : -
Extrait
This open-label, single-dose, parallel-group study will investigate the pharmacokinetics and safety of RO4917838 in healthy and renal impaired subjects. Subjects will receive a single dose of RO4917838.
Critère d'inclusion
- healthy volunteer